Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Next generation vaccines and vectors: Designing downstream processes for recombinant protein‐based virus‐like particles

CL Effio, J Hubbuch - Biotechnology journal, 2015 - Wiley Online Library
In recent years, the development of novel recombinant virus‐like particles (VLPs) has been
generating new perspectives for the prevention of untreated and arising infectious diseases …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors

PJ Woestenberg, AJ King… - The Journal of …, 2018 - academic.oup.com
Background Observational postmarketing studies are important to assess vaccine
effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine …

Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination …

EPF Chow, A Carter, T Vickers, CK Fairley… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

[HTML][HTML] Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review

L Mariani, P Vici, B Suligoi, G Checcucci-Lisi… - Advances in …, 2015 - Springer
Introduction Since 2007, many countries have implemented national human papillomavirus
(HPV) vaccination programs with the quadrivalent HPV (4HPV) vaccine that has been …

Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006–2014

EW Flagg, EA Torrone - American journal of public health, 2018 - ajph.aphapublications.org
Objectives. To detect decreases in anogenital warts (AGW) among sex and age groups
likely to be affected by human papillomavirus vaccination. Methods. We estimated annual …

The challenges for cancer chemoprevention

LK Penny, HM Wallace - Chemical Society Reviews, 2015 - pubs.rsc.org
The incidence of cancer is rising in parallel with an ageing populous thus increasing the
strain on both treatment options and budgets for healthcare providers worldwide. New …

Global human papilloma virus vaccine implementation: An update

S Sabeena, PV Bhat, V Kamath… - Journal of Obstetrics …, 2018 - Wiley Online Library
Human papillomavirus (HPV) infections continue to be one of the most common sexually
transmitted infections worldwide. The oncogenic potential of this virus was well established …

[HTML][HTML] The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis

A Lukács, Z Máté, N Farkas, A Mikó, J Tenk, P Hegyi… - BMC Public Health, 2020 - Springer
Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to
give protection against genital warts (GW) as well as cervical cancer. Our main question was …